MAPK1 and Miyoshi myopathy: That is, they found that MM cells have high amounts of SIRT6, which inhibit the activity of the target genes ELK1, RSK2 (ribosomal S6 kinase 2), and ERK2 in response to continuous DNA damage and genomic instability.